Stonehill Capital Management LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison
Ava Hoppe | 2 May, 2023
As an investor, keeping track of changes in fund holdings is essential. The latest 13F filings reveal that Stonehill Capital Management LLC has made some significant changes to its portfolio between the third and fourth quarters of 2022. In this article, we will delve deeper into these changes and analyze their potential implications.
Firstly, Stonehill Capital Management LLC sold 24,733 shares of Anterix Inc Common, reducing their position from 899,675 to 874,942. The estimated value of this holding decreased from $32.14 million to $28.15 million, marking a 12.4% change. Similarly, the company completely liquidated their position in Trinity Biotech PLC ADR, selling 579,597 shares between Q3 2022 and Q4 2022. This led to a value change from $2.22 million to $1.66 million, a 25.2% decline. The company also sold all of their holdings in Yandex NV - CLA Common and Tricida Inc SR Unsec Conv.
On the other hand, Stonehill Capital Management LLC bought 429,320 shares of Tenet Healthcare Corp Common, a new addition to their portfolio, with an estimated value of $20.95 million. Additionally, they acquired a significant number of shares in Tricida Inc Common, acquiring 1,198,443 and spending $12.56 million. Innovate Corp Common is also a new position that the company has acquired, holding 332,269 shares that are valued at $621,000.
Stonehill Capital Management LLC also increased its holdings in FiscalNote Holdings Inc Common, buying 7,703,906 additional shares to maintain the same number of shares in the portfolio but with an estimated increase in value from $9.29 million to $17.13 million. Unlike the above holdings where the company opened new positions, the option to purchase shares of IRSA ADR and Irsa Inversiones Sa WTS Exp 03/25/2026 were sold during Q3 2022.
Overall, Stonehill Capital Management LLC has made some significant changes to its portfolio, with some holdings being sold, while others are new additions. While this list isn't exhaustive of all of Stonehill Capital Management LLC's holdings changes, it offers investors insight into where the company has been investing its funds. It is always an excellent idea to keep track of your investments' performance and research for potential risks and benefits before investing in any funds or stocks.
Other Posts
- EyeSouth Partners Affiliates with Retina and Vitreous of Texas, Expanding Its Eye Care Network
- Mastrapasqua Asset Management Inc Q4 2022 vs. Q1 2023: A Comparative Analysis of Its Top 50 Holdings
- Examining EFG Asset Management's Q3-Q4 13F Holdings Changes: Winners, Losers, and Surprises
- Apple, Microsoft, and Alphabet Dominate Sonora Investment Q3 2021 Portfolio
- Denali Advisors LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Blue Wolf Capital: Stephen Madsen Joins as Managing Director, Business Development
- A Comprehensive Look into Buckingham Strategic Wealth's Q3 2022 vs. Q4 2022 13F Holdings
- Comparing Summit Trail Advisors Q3 vs. Q4 2022 13F Holdings: Which Companies Stand Out?
- Analyzing Ingalls & Snyder LLC’s Q3 Q4 2022 13F Holdings: Changes in Holdings and Investment Strategy
- The Profound Shifts in Pring Turner Capital Group's Portfolio: Q3 2022 vs. Q4 2022